Structures by: York G.
Total: 3
(S)-ethyl (1-((4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4- oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl) oxy)ethyl)
C25H29FN6O8
Organic Process Research & Development (2015) 19, 12 1882
a=9.4933(18)Å b=11.2461(19)Å c=24.486(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl (1-((4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido) propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl)oxy)ethyl)
C25H29FN6O8
Organic Process Research & Development (2015) 19, 12 1882
a=11.2744(3)Å b=9.4324(3)Å c=25.6466(7)Å
α=90.00° β=102.205(2)° γ=90.00°
(Z)-N-(2-(4-((4-fluorobenzyl)imino)-2,7-dimethyl-8-oxo-7,8-dihydro-4H-[1,3 dioxino[5,4-d]pyrimidin-6-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
C22H23FN6O5
Organic Process Research & Development (2015) 19, 12 1882
a=13.8135(4)Å b=13.3386(4)Å c=14.0876(4)Å
α=90° β=114.4961(11)° γ=90°